This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Hepatomegaly and splenomegaly, not elsewhere classified
R18_HEPATOM_SPLENO_NOT_ELSEW_CLASSIFIED
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
371 |
4. Check minimum number of eventsNone |
371 |
5. Include endpointsNone |
371 |
6. Filter based on genotype QC (FinnGen only) |
355 |
Control definitions (FinnGen only)
- Control exclude
- R18_SYMPTOMS_SIGNS_INVOLVI_DIGES_SYSTEM_ABDOMEN
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- R1
- Name in latin
- Hepatomegalia et/sive splenomegalia non alibi classificata
Similar endpoints
↥List of similar endpoints to
Hepatomegaly and splenomegaly, not elsewhere classified
based on the number of shared cases.
Similar with more cases:
- Symptoms and signs involving the digestive system and abdomen
- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 355 | 158 | 197 |
| Unadjusted period prevalence (%) | 0.08 | 0.06 | 0.09 |
| Median age at first event (years) | 53.18 | 48.46 | 56.97 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 371
- Matched controls
- 3710
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
R16.1
ICD-10 Finland
Splenomegaly, not elsewhere classified
10214.3
319.2
260
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
14.0
145.5
186
249
XW000
NOMESCO Finland
Bone marrow biopsy
18.7
108.0
94
66
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
9.8
91.9
135
205
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
8.0
89.4
189
428
R16.0
ICD-10 Finland
Hepatomegaly, not elsewhere classified
+∞
88.1
81
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
11.7
67.2
76
80
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
9.9
62.2
80
100
R16.2
ICD-10 Finland
Hepatomegaly with splenomegaly, not elsewhere classified
520.0
47.4
46
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
19.8
45.2
36
20
R50.9
ICD-10 Finland
Fever, unspecified
5.4
44.2
109
265
JN4BD
NOMESCO Finland
Extensive body CT
6.2
42.3
84
167
UJF32
NOMESCO Finland
Coloscopy
4.6
41.2
137
422
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.1
39.6
230
1049
JN3BD
NOMESCO Finland
Extensive abdominal CT
7.0
36.6
61
101
D73.1
ICD-10 Finland
Hypersplenism
+∞
34.9
33
*
R10.1
ICD-10 Finland
Pain localized to upper abdomen
5.5
33.7
75
164
D64.9
ICD-10 Finland
Anaemia, unspecified
5.4
33.0
74
163
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
14.0
32.7
31
24
R11
ICD-10 Finland
Nausea and vomiting
9.1
31.8
41
50
A49.9
ICD-10 Finland
Bacterial infection, unspecified
5.1
29.2
69
158
WW500
NOMESCO Finland
Blood transfusion
7.4
27.4
42
63
ZX120
NOMESCO Finland
Intravenous
5.0
27.1
66
155
JMA10
NOMESCO Finland
Transabdominal total splenectomy
65.0
26.4
30
5
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
10.0
23.8
28
30
C03DA01
ATC
spironolactone; oral
4.3
23.8
70
190
H02AB06
ATC
prednisolone; systemic
3.0
23.5
203
1073
J01MA12
ATC
levofloxacin; systemic
3.6
23.0
94
321
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
127.9
22.9
24
*
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
5.3
22.7
49
103
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
66.8
22.1
25
*
JN3AD
NOMESCO Finland
Abdominal CT examination
4.7
21.5
54
129
C03CA01
ATC
furosemide; systemic
3.0
21.4
128
548
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
3.9
20.9
71
213
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
9.2
20.9
26
30
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.1
20.8
115
470
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
7.4
20.7
31
45
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
7.3
20.3
31
46
UJF30
NOMESCO Finland
Ileoscopy through colon
4.4
20.1
56
145
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
19.5
19.4
29
16
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.3
18.8
85
307
JN4AD
NOMESCO Finland
Body CT examination
4.0
18.6
58
163
A02BC02
ATC
pantoprazole; systemic
2.8
18.6
259
1677
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
8.3
18.5
25
32
N02AX02
ATC
tramadol; systemic, rectal
2.6
17.5
174
949
M04AA01
ATC
allopurinol; systemic
3.4
17.3
72
246
R06.0
ICD-10 Finland
Dyspnoea
2.8
17.1
114
509
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
37.0
16.8
21
6
A10AE04
ATC
insulin glargine; parenteral
3.6
16.6
60
187
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
7.2
16.3
25
37
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
19.6
16.2
24
13
N03AX16
ATC
[U] pregabalin
2.9
16.2
95
396
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
+∞
15.7
15
*
R18
ICD-10 Finland
Ascites
166.7
15.6
16
*
A06AD11
ATC
lactulose; oral
3.3
15.2
65
225
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
7.1
15.0
23
34
A02BC01
ATC
omeprazole; systemic
2.6
14.9
108
499
A10AC01
ATC
insulin (human); parenteral
3.8
14.9
48
138
XF400
NOMESCO Finland
ECG with 12 standard connections
3.0
14.7
73
276
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
83.5
14.7
16
*
9689/3-C42.2
ICD-O-3
Splenic marginal zone B-cell lymphoma of spleen
+∞
14.7
14
*
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
3.5
14.5
55
176
UJF92
NOMESCO Finland
Capsular endoscopy
14.2
14.4
24
18
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.5
14.3
37
90
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
4.5
14.2
36
86
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.8
14.0
46
134
J01MA02
ATC
ciprofloxacin; systemic
2.4
13.8
146
800
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
12.1
13.5
24
21
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.4
13.3
53
175
JAH01
NOMESCO Finland
Laparoscopy
6.2
13.2
23
39
Z3231
NOMESCO Finland
Registered nurse
2.4
13.0
118
601
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
3.8
12.9
41
116
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.7
12.9
79
333
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
3.8
12.8
42
122
JN4CD
NOMESCO Finland
Very extensive body CT
5.8
12.8
24
44
103
Kela drug reimbursment
Diabetes, insulin-treated
2.4
12.7
117
599
JMA11
NOMESCO Finland
Laparoscopic total splenectomy
72.4
12.7
14
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.4
12.6
108
536
A10AB05
ATC
insulin aspart; parenteral
3.5
12.5
45
139
WZC00
NOMESCO Finland
Treatment plan or consultation
2.3
12.4
144
813
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
3.1
12.4
58
211
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
4.3
12.2
33
83
K76.9
ICD-10 Finland
Liver disease, unspecified
18.8
12.2
18
10
WW200
NOMESCO Finland
Immunization
5.9
12.1
22
39
TPH04
NOMESCO Finland
Cathetrisation of vein
2.5
12.0
90
418
SPAT1255
SPAT
Intravenous administration of medicine
4.2
12.0
33
84
AA1AD
NOMESCO Finland
CT of head and brain
2.4
11.9
100
490
WX892
NOMESCO Finland
Monitored bed care
3.6
11.9
41
123
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.4
11.7
108
551
Z94.4
ICD-10 Finland
Liver transplant status
67.1
11.7
13
*
A07AA02
ATC
nystatin; oral
4.7
11.7
28
64
127
Kela drug reimbursment
Transplant complication
14.2
11.6
19
14
F32.9
ICD-10 Finland
Depressive episode, unspecified
3.0
11.4
56
209
Z01.8
ICD-10 Finland
Other specified special examinations
2.5
11.2
86
403
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
20.8
11.2
16
8
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
25.9
11.2
15
6
XF600
NOMESCO Finland
Bloodpressure measurement
3.7
11.0
36
104
N06AX21
ATC
duloxetine; oral
3.3
11.0
43
140
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.3
11.0
100
506
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
4.2
11.0
30
76
J01FF01
ATC
clindamycin; systemic
2.3
11.0
106
550
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
5.4
10.9
22
43
UJD02
NOMESCO Finland
Gastroscopy
4.8
10.9
25
55
P01AB01
ATC
metronidazole; oral, rectal
2.1
10.9
140
816
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
4.2
10.8
30
77
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.3
10.8
44
147
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
3.4
10.8
40
126
Z2221
NOMESCO Finland
Medical doctor
2.2
10.6
113
610
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.0
10.5
50
183
JJC00
NOMESCO Finland
Allogenic transplantation of liver
113.1
10.5
11
*
L03AA02
ATC
filgrastim; parenteral
5.1
10.4
22
45
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
33.6
10.4
13
*
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.5
10.4
75
341
D01
ICPC
Abdominal pain/cramps general
3.2
10.4
43
145
M54.5
ICD-10 Finland
Low back pain
2.1
10.3
132
764
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
5.5
10.2
20
38
ZXD05
NOMESCO Finland
Urgent procedure
2.2
10.2
115
633
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.6
10.2
65
278
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.4
10.2
80
378
WX302
NOMESCO Finland
Thoracal epidural anesthesy
4.3
10.1
27
67
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
9.5
10.1
20
22
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
2.2
10.1
108
582
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.9
10.1
30
81
N02AA05
ATC
oxycodone; systemic
2.7
10.0
62
261
D06
ICPC
Abdominal pain localized other
3.8
10.0
32
91
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.4
10.0
84
409
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.2
10.0
113
623
A02BC05
ATC
esomeprazole; systemic
2.1
9.9
137
814
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
4.4
9.8
25
60
TPH07
NOMESCO Finland
Cathetrisation of artery
2.9
9.7
49
185
D70.89
ICD-10 Finland
Neutropenic splenomegaly
11.8
9.7
17
15
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
30.9
9.5
12
*
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.4
9.4
35
110
E66.8
ICD-10 Finland
Other obesity
4.3
9.4
25
62
L04AX01
ATC
azathioprine; systemic
4.3
9.4
25
62
L04AD01
ATC
ciclosporin; systemic
9.9
9.4
18
19
WX110
NOMESCO Finland
Infiltration anesthesia
2.1
9.4
270
2071
J01MA14
ATC
moxifloxacin; systemic
3.1
9.3
40
138
C07AB07
ATC
bisoprolol; oral
2.0
9.2
173
1140
Z2446
NOMESCO Finland
Social worker
3.2
9.2
38
128
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
4.0
9.1
26
68
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
37.7
9.1
11
*
JCA22
NOMESCO Finland
Endoscopic ligature of oesophageal varices
37.7
9.1
11
*
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
24.7
9.0
12
5
L04AA06
ATC
mycophenolic acid; systemic
11.1
8.9
16
15
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
3.2
8.8
37
126
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.9
8.8
43
160
WX002
NOMESCO Finland
Sedation and analgesia
2.3
8.7
73
353
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
51.2
8.7
10
*
Z3226
NOMESCO Finland
Physiotherapist
2.3
8.7
78
389
ZXE00
NOMESCO Finland
One hour or less
1.9
8.6
150
960
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
28.2
8.5
11
*
A99
ICPC
Disease/condition unspecnature/site
3.1
8.5
36
123
TK800
NOMESCO Finland
Hemodialysis
8.2
8.5
18
23
JJ9AE
NOMESCO Finland
Ultrasound examination of liver transplant
92.1
8.4
9
*
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.5
8.4
29
87
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
2.3
8.4
73
359
K74.0
ICD-10 Finland
Hepatic fibrosis
+∞
8.4
8
*
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
7.4
8.4
19
27
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
9.8
8.4
16
17
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
14.9
8.3
13
9
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
4.7
8.2
19
42
N06AX11
ATC
mirtazapine; oral
2.0
8.2
113
664
E66.01
ICD-10 Finland
Obesity due to excess calories
2.9
8.2
39
143
N06AX16
ATC
venlafaxine; oral
2.6
8.1
52
222
R10.0
ICD-10 Finland
Acute abdomen
17.7
8.1
12
7
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
17.7
8.1
12
7
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
34.2
8.1
10
*
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
3.9
8.0
24
65
A02BC03
ATC
lansoprazole; oral
2.1
8.0
94
520
A10BA02
ATC
metformin; oral
2.0
8.0
111
653
H02AB09
ATC
hydrocortisone; systemic
6.8
8.0
19
29
A05AA02
ATC
ursodeoxycholic acid; oral
8.0
8.0
17
22
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.3
7.9
31
101
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.7
7.8
45
182
N06AA09
ATC
amitriptyline; systemic
3.0
7.8
36
129
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.9
7.8
160
1070
R51.80
ICD-10 Finland
Headache
2.4
7.8
58
266
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.9
7.8
191
1352
T90
ICPC
Diabetes non-insulin dependent
2.1
7.8
93
518
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
2.0
7.8
109
643
I85.0
ICD-10 Finland
Oesophageal varices with bleeding
46.0
7.7
9
*
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
4.7
7.7
18
40
B01AB05
ATC
enoxaparin; parenteral
2.0
7.7
110
652
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
3.8
7.7
24
67
N05CF01
ATC
zopiclone; oral
2.0
7.7
109
645
I81
ICD-10 Finland
Portal vein thrombosis
25.6
7.6
10
*
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.1
7.5
89
494
K92.0
ICD-10 Finland
Haematemesis
7.9
7.5
16
21
174
Kela drug reimbursment
Ruxolitinib
81.7
7.4
8
*
374
Kela drug reimbursment
Ruxolitinib
81.7
7.4
8
*
D73.9
ICD-10 Finland
Disease of spleen, unspecified
81.7
7.4
8
*
WZC30
NOMESCO Finland
Teaching
2.3
7.4
62
299
D11
ICPC
Diarrhoea
2.6
7.3
44
182
D73.5
ICD-10 Finland
Infarction of spleen
+∞
7.3
7
*
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.3
7.3
28
90
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
4.5
7.3
18
42
M54.4
ICD-10 Finland
Lumbago with sciatica
2.2
7.3
65
322
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.0
7.3
87
483
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
16.1
7.3
11
7
A07EA06
ATC
budesonide; oral, local oral
4.1
7.3
20
51
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
3.6
7.2
24
70
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
3.2
7.1
29
97
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
7.2
7.1
16
23
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.8
7.1
35
131
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
4.5
7.0
17
39
M79.6
ICD-10 Finland
Pain in limb
1.8
7.0
136
887
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.2
7.0
67
342
PJA10
NOMESCO Finland
Exploration of lymph nodes
7.8
7.0
15
20
K92.1
ICD-10 Finland
Melaena
3.6
7.0
23
67
SPAT1254
SPAT
Administration of medicine
2.3
6.9
53
246
A03FA01
ATC
metoclopramide; systemic, rectal
2.1
6.9
73
387
H02AB07
ATC
prednisone; oral
2.4
6.9
51
233
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.5
6.8
46
201
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.4
6.8
17
40
R4110
NOMESCO Finland
Physiotherapy
1.9
6.8
104
628
R03AC02
ATC
salbutamol; inhalant
1.8
6.8
195
1427
K70.4
ICD-10 Finland
Alcoholic hepatic failure
40.8
6.8
8
*
R15
ICD-10 Finland
Faecal incontinence
17.1
6.8
10
6
L04AD02
ATC
tacrolimus; systemic
17.1
6.8
10
6
B03XA02
ATC
darbepoetin alfa; parenteral
6.6
6.7
16
25
K73.2
ICD-10 Finland
Chronic active hepatitis, not elsewhere classified
23.0
6.7
9
*
K59.09
ICD-10 Finland
Constipation, unspecified
3.3
6.7
25
79
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
3.3
6.7
25
79
TGC00
NOMESCO Finland
Bronchial lavation
6.1
6.7
17
29
L01XX05
ATC
hydroxycarbamide; oral
8.0
6.7
14
18
N17.9
ICD-10 Finland
Acute renal failure, unspecified
4.0
6.6
19
50
C05AA08
ATC
fluocortolone; rectal, topical
2.4
6.6
49
224
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
3.0
6.6
30
107
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
7.1
6.6
15
22
A10AE05
ATC
insulin detemir; parenteral
3.1
6.6
28
96
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
10.3
6.6
12
12
D45
ICD-10 Finland
Polycythaemia vera
10.3
6.6
12
12
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.9
6.6
31
113
C08CA01
ATC
amlodipine; oral
1.8
6.5
129
843
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
3.0
6.5
29
102
J01DB01
ATC
cefalexin; oral
2.0
6.5
297
2483
L01EJ01
ATC
ruxolitinib; oral
71.0
6.4
7
*
K72.1
ICD-10 Finland
Chronic hepatic failure
71.0
6.4
7
*
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
71.0
6.4
7
*
D68.8
ICD-10 Finland
Other specified coagulation defects
14.6
6.4
10
7
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.6
6.4
37
150
H02AB04
ATC
methylprednisolone; systemic
2.3
6.4
49
227
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
3.3
6.4
24
76
R51
ICD-10 Finland
Headache
3.7
6.4
20
56
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
6.7
6.4
15
23
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
11.3
6.3
11
10
ZXE10
NOMESCO Finland
More than one and less than three hours
1.8
6.3
124
808
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
3.3
6.3
23
72
K29.8
ICD-10 Finland
Duodenitis
27.2
6.3
8
*
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
3.0
6.2
28
99
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
3.7
6.2
20
57
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.2
6.2
55
271
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.9
6.2
29
105
N30.0
ICD-10 Finland
Acute cystitis
2.3
6.2
50
237
R07.4
ICD-10 Finland
Chest pain, unspecified
1.9
6.2
88
518
I50.9
ICD-10 Finland
Heart failure, unspecified
2.3
6.2
46
211
SPAT1262
SPAT
Handing over of treatment supplies
2.1
6.2
66
351
A41.9
ICD-10 Finland
Sepsis, unspecified
4.2
6.1
16
39
R4190
NOMESCO Finland
Nutritional therapy
3.7
6.1
19
53
K75.9
ICD-10 Finland
Inflammatory liver disease, unspecified
12.8
6.1
10
8
R60.9
ICD-10 Finland
Oedema, unspecified
3.4
6.1
22
68
JJ1LE
NOMESCO Finland
Ultrasound elastography of liver
8.8
6.1
12
14
A03
ICPC
Fever
2.1
6.1
65
345
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
10.3
6.1
11
11
R03BB04
ATC
tiotropium bromide; inhalant
2.5
6.1
39
167
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.5
6.0
40
174
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
189
280
12.72
136.17
8.0
4.6
251.11
259.27
u/l
0.17
184
271
171
286
10.24
109.11
4.9
2.9
1.86
1.74
%
0.70
161
262
135
201
9.99
93.50
3.4
3.3
10.42
10.47
g/l
0.03
130
182
136
210
9.65
91.23
4.9
2.5
78.26
70.19
e9/l
1.29
107
163
117
166
9.83
83.59
2.1
1.9
1.30
1.32
g/l
0.03
108
153
70
52
16.36
77.11
1.7
1.9
—
—
—
0
0
87
100
11.06
72.48
2.2
2.5
1.24
1.42
g/l
0.71
70
85
127
233
7.77
71.74
3.1
1.9
0.21
0.22
g/l
1.02
121
218
143
334
6.34
62.63
3.5
2.4
20.17
23.06
%
1.51
133
298
283
1218
6.58
60.38
15.7
5.8
14.25
12.16
umol/l
0.77
277
1149
121
259
6.45
57.64
7.8
2.3
8.72
8.32
umol/l
0.07
107
226
140
354
5.75
55.44
3.5
2.3
2.35
2.35
g/l
0.05
133
336
146
388
5.56
54.51
3.5
2.3
11.77
13.38
umol/l
1.75
138
366
276
1317
5.28
47.47
12.6
5.7
57.12
56.42
%
0.37
267
1248
274
1303
5.22
47.25
13.6
5.8
2.98
2.90
%
0.17
265
1230
63
82
9.05
46.96
2.4
4.0
29.13
35.51
mg/l
0.50
52
66
64
85
8.89
46.93
1.7
2.4
—
—
—
0
0
278
1343
5.27
46.80
13.7
5.8
27.88
28.57
%
0.43
269
1273
62
82
8.88
45.58
2.5
4.0
49.34
124.33
mg/l
0.48
51
66
244
1091
4.61
44.88
9.9
4.1
35.77
36.08
g/l
0.35
238
1009
49
54
10.30
41.32
1.8
1.5
—
—
—
0
0
294
1569
5.21
41.22
19.6
9.0
3.94
3.99
e9/l
0.12
268
1362
245
1152
4.32
40.71
12.7
6.0
1.21
1.21
mmol/l
0.85
240
1045
255
1259
4.28
38.90
13.1
6.5
1.21
1.21
mmol/l
0.66
223
1076
171
648
4.04
38.24
10.5
3.5
83.27
90.48
%
3.12
165
634
49
61
9.10
37.60
1.5
1.1
—
—
—
0
0
159
579
4.06
37.53
2.0
1.5
2.14
2.32
g/l
0.51
121
346
176
688
3.96
37.48
4.7
2.7
340.37
9083.06
umol/l
3.57
169
614
166
641
3.88
35.65
3.5
1.9
3.85
2.94
mg/l
3.37
161
556
44
51
9.65
35.62
1.9
1.5
120.50
100.55
u/ml
—
8
11
46
58
8.91
34.88
1.7
1.1
277.73
271.21
u/ml
0.03
30
33
191
833
3.66
33.69
6.7
2.8
34.67
31.80
u/l
0.69
181
786
120
386
4.12
33.21
2.2
1.7
—
—
—
0
0
234
1176
3.68
32.76
5.2
2.6
201.33
125.07
ug/l
1.73
227
1079
159
648
3.54
30.58
4.0
2.1
47.57
64.60
u/l
1.62
150
593
224
1147
3.40
29.37
15.9
13.4
1.25
1.27
inr
0.12
72
339
84
229
4.45
28.70
11.2
6.7
10.48
9.65
mmol/l
0.42
84
215
65
146
5.19
28.12
2.3
1.7
—
—
—
0
0
29
27
11.57
27.21
1.4
1.1
—
—
—
0
0
116
429
3.48
25.33
1.8
1.7
1276.31
1154.95
nmol/l
0.46
99
335
69
185
4.35
23.86
4.7
1.9
30.15
59.40
u/l
0.66
60
157
183
910
3.00
23.80
5.3
2.9
—
—
—
0
0
307
2049
3.89
23.60
20.0
6.6
95.50
79.06
u/l
4.07
300
1896
47
95
5.52
22.73
1.2
1.4
—
—
—
0
0
129
539
3.14
22.70
3.4
1.6
1.92
1.11
mg/l
0.97
110
407
161
766
2.95
22.41
5.6
2.9
62.42
152.58
e6/l
0.43
134
581
122
508
3.09
21.43
4.3
2.3
5.24
3.99
e6/l
0.83
112
456
88
302
3.51
21.26
10.6
7.2
104.18
104.76
mmol/l
0.50
88
302
75
235
3.75
20.76
8.8
4.2
1.10
1.44
mmol/l
0.41
63
197
300
2049
3.43
20.55
7.3
3.6
13.61
11.29
mm/h
1.80
292
1875
43
90
5.27
19.96
8.4
3.2
1.57
1.43
mg/l
0.46
43
82
80
271
3.49
19.62
2.3
1.6
—
—
—
0
0
80
271
3.49
19.62
2.4
1.7
—
—
—
0
0
189
1040
2.67
19.09
2.5
1.9
91.79
96.30
pmol/l
0.52
126
541
193
1075
2.66
18.99
3.5
2.2
71.96
77.02
nmol/l
1.56
188
959
32
53
6.51
18.90
1.6
1.2
—
—
—
0
0
135
632
2.79
18.76
4.0
2.0
—
—
—
0
0
26
35
7.91
18.47
4.1
2.2
31.81
33.57
pg
0.94
26
35
143
703
2.68
17.90
5.5
2.8
0.60
0.33
e6/l
0.38
114
523
246
1572
2.68
17.82
10.5
4.5
7.26
6.71
mmol/l
2.61
241
1443
133
633
2.72
17.73
1.4
1.3
0.74
1.11
u/ml
0.88
31
161
31
56
5.95
16.78
2.0
1.6
—
—
—
0
0
31
56
5.95
16.78
5.3
3.4
56.10
56.02
%
0.01
31
56
209
1259
2.51
16.78
4.7
2.4
—
—
—
0
0
28
21
14.32
16.76
2.3
2.9
—
—
—
0
0
25
14
19.03
16.70
4.4
2.3
87.44
99.43
%
0.53
25
14
60
188
3.61
16.43
6.1
4.1
118.47
82.71
ng/l
0.51
55
170
26
40
6.91
16.42
1.8
1.6
—
—
—
0
0
24
34
7.48
16.30
1.2
1.0
—
—
—
0
0
139
702
2.57
16.17
4.4
3.1
1423.26
1189.80
ng/l
0.29
122
613
35
75
5.05
15.75
2.0
2.9
—
—
—
0
0
30
56
5.74
15.69
2.0
1.5
—
—
—
0
0
29
53
5.85
15.50
4.6
2.9
3.50
4.22
e9/l
0.68
29
53
25
41
6.47
14.86
1.5
1.1
—
—
—
0
0
255
1739
2.49
14.82
5.6
3.6
85.75
1294.56
e6/l
—
8
27
121
599
2.51
14.43
1.9
1.5
18.44
20.12
nmol/l
0.59
115
502
92
410
2.65
13.54
4.3
2.7
3.44
1.66
e6/l
1.11
54
229
20
11
19.14
13.52
1.3
2.1
—
—
—
0
0
20
11
19.14
13.52
1.3
2.1
—
—
—
0
0
47
142
3.64
13.52
2.0
1.5
—
—
—
0
0
21
14
15.82
13.25
2.5
2.1
1686.19
858.57
u/ml
0.97
21
14
23
39
6.22
13.22
1.6
1.6
—
—
—
0
0
23
39
6.22
13.22
1.6
1.6
—
—
—
0
0
157
905
2.27
13.00
4.2
3.1
20.14
45.14
ng/l
4.11
112
631
26
51
5.41
12.88
1.2
1.5
—
—
—
0
0
76
315
2.78
12.84
2.8
2.5
123.58
134.39
ug/g
0.12
66
247
34
87
4.20
12.29
1.7
1.5
0.00
0.04
iu/ml
—
7
18
53
184
3.19
12.24
18.2
8.0
24.01
24.82
mmol/l
0.74
53
184
22
21
11.06
11.92
2.3
2.1
480.27
632.86
e6/l
0.78
22
21
91
430
2.48
11.71
4.0
2.6
1.23
0.79
e6/l
0.76
52
248
45
145
3.39
11.71
13.0
4.7
24.01
23.65
mmol/l
0.46
45
145
22
41
5.64
11.49
1.2
1.0
—
—
—
0
0
78
346
2.59
11.44
2.4
1.7
1.55
1.37
%
1.32
72
312
52
187
3.07
11.30
2.2
2.1
55.79
68.41
ml/min/173m2
1.07
24
76
153
912
2.15
11.30
4.5
3.3
6.96
8.11
mmol/l
2.58
139
771
23
27
9.01
11.20
1.3
1.2
—
—
—
0
0
50
177
3.11
11.15
6.7
3.5
1.59
1.63
mmol/l
0.02
38
129
51
189
2.97
10.50
6.8
3.4
5.00
5.11
kpa
0.40
51
177
65
276
2.64
10.36
13.6
8.3
0.12
0.85
mmol/l
0.63
53
235
21
25
8.83
10.19
1.0
1.0
—
—
—
0
0
35
105
3.58
10.13
4.9
2.9
0.73
0.65
%
0.42
35
105
19
19
10.47
10.13
1.7
1.3
—
—
—
0
0
143
863
2.07
9.95
5.5
3.9
33.86
7.97
mg/mmol
1.16
98
570
257
1915
2.11
9.93
7.4
2.7
76.24
44.53
u/l
6.51
248
1788
22
47
4.91
9.90
1.5
1.3
327.94
284.89
ug/g
0.34
17
24
19
37
5.36
9.46
3.9
2.9
15.32
14.61
%
—
10
17
21
45
4.89
9.41
7.9
4.4
4.97
5.02
kpa
0.09
21
45
9
0
+∞
9.41
1.0
0.0
—
—
—
0
0
195
1334
1.97
9.37
4.9
3.1
0.00
0.00
estimate
0.50
43
244
139
848
2.02
9.25
5.2
3.2
2.33
2.36
mmol/l
1.65
130
762
35
112
3.35
9.18
4.9
2.9
1.98
1.27
%
1.54
35
112
195
1350
1.94
8.89
5.1
3.1
0.00
0.01
estimate
0.50
39
214
31
94
3.51
8.83
1.9
1.9
—
—
—
0
0
26
70
3.92
8.77
1.7
1.7
—
—
—
0
0
21
33
6.68
8.61
2.0
1.4
—
—
—
0
0
12
6
20.60
8.52
3.1
2.2
—
—
—
0
0
44
170
2.80
8.37
17.8
9.7
0.63
0.69
%
0.42
44
170
44
171
2.78
8.28
17.8
9.5
1.38
1.39
%
0.02
44
171
52
222
2.56
8.14
2.7
4.4
4.06
40.35
ug/l
0.63
38
184
24
65
3.88
8.04
1.5
1.2
19.27
2.28
u/ml
—
7
15
190
1334
1.87
8.01
7.1
4.2
0.00
0.00
estimate
-0.00
44
235
21
52
4.22
7.91
3.2
2.2
23.36
24.16
mmol/l
0.29
21
52
18
40
4.68
7.73
6.3
6.1
11.30
10.30
mg/l
0.35
18
35
20
49
4.26
7.64
1.6
1.2
—
—
—
0
0
20
49
4.26
7.64
1.6
1.2
—
—
—
0
0
13
11
12.19
7.63
1.0
1.0
—
—
—
0
0
14
14
10.34
7.59
4.9
2.9
—
—
—
0
0
27
83
3.43
7.54
1.9
1.9
—
—
—
0
0
38
145
2.81
7.39
1.9
1.3
—
—
—
0
0
17
25
7.07
7.38
2.1
1.6
—
—
—
0
0
90
505
2.03
7.33
2.1
1.6
466.57
414.36
pmol/l
0.73
79
422
80
430
2.10
7.31
1.5
1.2
28.68
33.92
iu/ml
0.15
23
124
7
0
+∞
7.31
3.7
0.0
—
—
—
0
0
83
455
2.06
7.19
5.0
3.5
525.00
692.96
ng/l
0.17
60
361
56
262
2.34
7.18
4.3
3.0
—
—
—
0
0
19
47
4.21
7.17
1.6
1.3
—
—
—
0
0
16
23
7.22
7.07
1.9
1.9
—
—
—
0
0
269
2161
1.89
6.89
4.5
3.7
14.62
14.76
pmol/l
0.43
253
1951
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
26
84
3.25
6.73
7.0
2.6
0.29
0.34
u/ml
0.53
15
40
17
29
6.09
6.69
2.7
2.4
2.04
1.68
mmol/l
0.79
17
29
27
90
3.16
6.65
2.0
1.8
—
—
—
0
0
16
26
6.38
6.54
1.5
1.2
—
—
—
0
0
52
246
2.30
6.49
15.5
8.6
111.88
121.29
g/l
2.26
52
241
26
86
3.18
6.48
8.6
3.4
9.19
8.76
kpa
0.41
26
81
11
10
11.29
6.33
3.2
1.2
—
—
—
0
0
12
13
9.49
6.33
1.1
1.9
16.83
11.00
u/l
1.64
12
13
6
0
+∞
6.26
4.8
0.0
88.17
—
ug/min
—
6
0
16
28
5.92
6.21
1.1
1.2
—
—
—
0
0
75
417
2.00
6.19
1.4
1.3
3.88
8.33
u/ml
0.71
22
150
16
29
5.72
6.06
1.7
1.4
—
—
—
0
0
16
29
5.72
6.06
1.7
1.4
—
—
—
0
0
18
49
3.81
5.99
2.2
1.4
—
—
—
0
0
19
54
3.65
5.96
1.1
1.1
—
—
—
0
0
10
9
11.38
5.82
1.1
1.0
—
—
—
0
0
111
716
1.79
5.77
5.0
3.4
0.00
0.02
estimate
0.68
38
229
23
76
3.16
5.75
2.5
1.7
—
—
—
0
0
333
2941
2.29
5.73
35.3
11.0
19.54
23.66
mg/l
2.09
301
2169
22
71
3.23
5.71
2.5
2.4
417.99
65.89
ug/min
1.11
13
37
19
56
3.52
5.66
1.3
1.2
—
—
—
0
0
9
7
13.13
5.61
1.2
3.0
267.56
128.57
%
—
9
7
15
28
5.54
5.59
2.0
1.7
—
—
—
0
0
8
5
16.30
5.43
1.0
1.0
—
—
—
0
0
16
34
4.87
5.36
1.7
1.3
—
—
—
0
0
9
8
11.49
5.31
1.2
1.0
—
—
—
0
0
15
40
3.87
5.14
1.5
1.3
100.27
64.65
pmol/l
0.68
15
40
8
6
13.59
5.10
6.5
2.3
203.63
231.17
u/l
—
8
6
8
6
13.59
5.10
1.1
1.2
85.88
80.33
%
—
8
6
13
24
5.57
4.96
3.7
1.4
—
—
—
0
0
13
26
5.14
4.67
1.2
1.2
—
—
—
0
0
305
2665
1.81
4.61
5.7
4.3
2.07
1.92
mu/l
1.42
291
2423
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
9
11
8.35
4.58
1.2
2.3
215.22
130.27
%
—
9
11
12
23
5.35
4.49
1.4
1.6
—
—
—
0
0
12
23
5.35
4.49
1.4
1.6
—
—
—
0
0
12
23
5.35
4.49
1.4
1.6
—
—
—
0
0
12
24
5.13
4.35
1.2
1.5
—
—
—
0
0
8
9
9.05
4.30
5.1
1.6
16.63
31.00
umol/l
—
8
9
7
6
11.86
4.29
1.7
1.3
—
—
—
0
0
12
25
4.92
4.22
2.8
2.2
89.69
86.55
%
0.85
12
25
140
1031
1.57
4.16
5.1
3.2
—
—
—
0
0
29
130
2.34
4.11
4.6
2.4
0.18
0.14
e6/l
0.13
29
122
10
18
5.68
4.00
2.4
1.4
—
—
—
0
0
12
28
4.39
3.85
2.5
1.6
—
—
—
0
0
12
29
4.24
3.73
2.5
1.6
—
—
—
0
0
307
2739
1.70
3.67
30.7
11.0
82.58
83.00
ml/min/173m2
0.10
281
2189
19
74
2.65
3.61
1.4
1.2
—
—
—
0
0
19
74
2.65
3.61
1.4
1.2
—
—
—
0
0
17
63
2.78
3.54
1.2
1.0
—
—
—
0
0
8
13
6.26
3.52
1.1
4.0
57.75
87.62
nmol/l
—
8
13
16
58
2.84
3.46
1.5
1.6
1.01
0.84
nmol/l
0.42
11
49
13
42
3.17
3.40
1.2
1.1
—
—
—
0
0
7
10
7.11
3.37
1.4
2.0
—
—
—
0
0
7
10
7.11
3.37
1.4
2.0
—
—
—
0
0
13
38
3.51
3.34
1.8
1.3
—
—
—
0
0
11
28
4.02
3.31
2.6
1.6
—
—
—
0
0
11
29
3.88
3.21
2.6
1.6
—
—
—
0
0
11
29
3.88
3.21
2.6
1.6
—
—
—
0
0
11
29
3.88
3.21
2.6
1.6
—
—
—
0
0
9
20
4.58
3.13
2.3
1.4
0.85
1.00
g/l
—
9
20
10
25
4.08
3.10
4.7
3.6
—
—
—
0
0
6
8
7.60
3.06
1.3
2.0
—
—
—
0
0
6
8
7.60
3.06
1.3
2.0
—
—
—
0
0
5
5
10.11
2.98
1.8
1.0
92.20
103.20
%
—
5
5
7
13
5.47
2.88
2.0
1.3
—
—
—
0
0
6
9
6.75
2.88
1.3
1.9
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
6
9
6.75
2.88
1.5
1.1
97.00
120.56
%
—
6
9
11
33
3.40
2.83
1.9
1.4
—
—
—
0
0
15
59
2.61
2.82
2.9
1.4
—
—
—
0
0
5
6
8.42
2.75
1.2
1.2
—
—
—
0
0
27
140
2.00
2.73
6.5
6.9
24.04
24.45
mmol/l
0.17
27
135
9
24
3.82
2.69
1.0
1.0
—
—
—
0
0
13
49
2.71
2.65
1.6
1.6
—
—
—
0
0
7
15
4.73
2.61
1.3
1.2
—
—
—
0
0
9
25
3.66
2.59
1.1
1.2
—
—
—
0
0
8
20
4.06
2.58
1.4
1.2
—
—
—
0
0
8
20
4.06
2.58
1.4
1.2
—
—
—
0
0
8
20
4.06
2.58
1.4
1.2
—
—
—
0
0
8
20
4.06
2.58
1.4
1.2
—
—
—
0
0
8
20
4.06
2.58
1.4
1.2
—
—
—
0
0
6
11
5.52
2.55
1.0
1.1
1419.67
1237.64
miu/ml
—
6
11
78
558
1.50
2.50
1.8
1.5
—
—
—
0
0
7
16
4.44
2.48
1.0
1.0
297.71
238.81
iu/ml
—
7
16
17
76
2.30
2.48
4.5
3.4
3.83
3.94
mmol/l
0.52
17
76
8
21
3.87
2.47
1.4
1.5
—
—
—
0
0
9
27
3.39
2.41
4.2
2.4
—
—
—
0
0
290
2637
1.46
2.33
40.2
13.8
15.76
14.82
%
1.94
285
2586
12
47
2.61
2.29
1.1
1.2
—
—
—
0
0
6
13
4.67
2.28
2.2
1.3
—
—
—
0
0
6
13
4.67
2.28
1.2
1.6
—
—
—
0
0
5
9
5.61
2.22
1.2
1.0
—
—
—
0
0
100
769
1.41
2.19
1.7
1.6
1.55
1.37
mmol/l
0.88
88
655
6
15
4.05
2.04
1.0
1.5
14.50
9.87
u/l
—
6
15
8
27
3.00
1.94
6.4
2.3
106.63
105.89
mmol/l
—
8
27
6
16
3.79
1.94
1.5
1.1
—
—
—
0
0
6
16
3.79
1.94
2.2
1.3
—
—
—
0
0
8
28
2.90
1.87
1.3
1.3
—
—
—
0
0
12
54
2.26
1.75
1.4
1.2
83.14
21.70
e6/l
—
7
44
5
13
3.88
1.72
1.4
1.5
2.06
1.77
mmol/l
—
5
13
14
69
2.07
1.67
3.1
3.7
35.67
22.34
mg/l
—
9
49
17
92
1.89
1.58
1.5
1.3
203.03
264.54
miu/ml
—
7
47
222
1991
1.29
1.58
3.6
3.0
—
—
—
0
0
14
71
2.01
1.56
1.6
1.3
—
—
—
0
0
5
15
3.36
1.53
2.2
1.3
—
—
—
0
0
5
15
3.36
1.53
2.2
1.3
—
—
—
0
0
5
15
3.36
1.53
1.2
1.2
—
—
—
0
0
301
2822
1.35
1.48
5.3
4.3
6.36
5.94
mmol/l
4.12
288
2568
285
2659
1.31
1.39
8.2
5.4
41.41
39.72
mmol/mol
1.58
272
2482
27
180
1.54
1.25
1.3
1.2
83.00
138.72
iu/ml
0.51
12
75
5
19
2.65
1.22
1.0
6.2
—
39.60
—
0
5
297
2805
1.29
1.19
4.5
3.8
1.49
1.28
mmol/l
2.90
283
2598
5
20
2.52
1.15
2.2
1.1
—
—
—
0
0
5
20
2.52
1.15
2.2
1.1
—
—
—
0
0
307
2916
1.31
1.15
5.0
4.2
4.27
4.61
mmol/l
7.33
290
2720
22
144
1.56
1.11
1.5
1.4
—
—
—
0
0
7
31
2.28
1.11
1.0
1.2
—
—
—
0
0
7
33
2.14
1.06
1.1
1.1
—
—
—
0
0
19
283
0.65
1.01
1.6
1.6
—
—
—
0
0
5
23
2.19
0.98
1.0
1.0
—
—
—
0
0
6
27
2.24
0.94
1.2
1.0
—
—
—
0
0
6
27
2.24
0.94
1.2
1.0
—
—
—
0
0
49
388
1.30
0.91
2.9
2.0
—
—
—
0
0
6
30
2.02
0.87
1.8
2.4
14.17
13.05
%
—
6
30
309
2971
1.24
0.80
5.5
4.6
2.52
2.75
mmol/l
4.61
297
2760
26
194
1.37
0.73
1.8
2.0
—
—
—
0
0
44
357
1.26
0.70
2.9
1.9
—
—
—
0
0
301
2901
1.20
0.67
4.9
4.2
1.25
1.43
mmol/l
10.60
282
2698
10
64
1.58
0.59
1.5
1.2
—
—
—
0
0
7
112
0.62
0.59
2.0
2.0
—
—
—
0
0
12
172
0.69
0.57
1.7
1.6
—
—
—
0
0
8
57
1.41
0.42
1.6
1.5
—
—
—
0
0
10
70
1.44
0.42
1.4
1.5
—
—
—
0
0
0
18
0.00
0.40
0.0
2.1
—
—
—
0
0
7
104
0.67
0.40
1.1
1.4
—
—
—
0
0
7
104
0.67
0.40
1.1
1.4
—
—
—
0
0
7
105
0.66
0.40
1.3
1.4
—
—
—
0
0
7
105
0.66
0.40
1.3
1.4
—
—
—
0
0
10
71
1.42
0.39
3.1
1.7
162.60
238.31
pmol/l
—
10
64
8
112
0.71
0.38
1.4
1.6
—
—
—
0
0
20
164
1.23
0.33
1.7
1.8
—
—
—
0
0
62
674
0.90
0.27
3.1
2.9
0.83
0.76
ug/l
0.26
46
438
118
1120
1.08
0.25
4.5
4.7
1.93
2.32
ug/l
0.54
109
995
84
895
0.92
0.25
3.6
4.1
23.13
21.41
%
0.40
38
419
16
133
1.21
0.24
1.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
5
69
0.72
0.17
1.6
1.6
—
—
—
0
0
5
45
1.11
0.10
1.0
1.1
—
2.88
—
0
21
38
366
1.04
0.05
1.5
1.5
—
—
—
0
0
34
327
1.04
0.05
8.1
6.0
—
—
—
0
0
11
102
1.08
0.03
2.8
1.6
33.45
39.08
nmol/l
0.67
11
97
341
3405
1.02
0.00
51.7
16.8
38.73
40.64
%
5.62
329
3186
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
30.68
—
0
6
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
3.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
6.79
—
0
8
0
7
0.00
-0.00
0.0
5.7
—
—
—
0
0
0
9
0.00
-0.00
0.0
3.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: R18_HEPATOM_SPLENO_NOT_ELSEW_CLASSIFIED – Hepatomegaly and splenomegaly, not elsewhere classified
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).